Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection

Mathieu Iampietro, Patrick Younan, Andrew Nishida, Mukta Dutta, Ndongala Michel Lubaki, Rodrigo I. Santos, Richard A. Koup, Michael G. Katze, Alexander Bukreyev

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Fatal outcomes of Ebola virus (EBOV) infections are typically preceded by a ‘sepsis-like’ syndrome and lymphopenia despite T cells being resistant to Ebola infection. The mechanisms that lead to T lymphocytes death remain largely unknown; however, the degree of lymphopenia is highly correlative with fatalities. Here we investigated whether the addition of EBOV or its envelope glycoprotein (GP) to isolated primary human CD4+T cells induced cell death. We observed a significant decrease in cell viability in a GP-dependent manner, which is suggestive of a direct role of GP in T cell death. Using immunoprecipitation assays and flow cytometry, we demonstrate that EBOV directly binds to CD4+T cells through interaction of GP with TLR4. Transcriptome analysis revealed that the addition of EBOV to CD4+T cells results in the significant upregulation of pathways associated with interferon signaling, pattern recognition receptors and intracellular activation of NFκB signaling pathway. Both transcriptome analysis and specific inhibitors allowed identification of apoptosis and necrosis as mechanisms associated with the observed T cell death following exposure to EBOV. The addition of the TLR4 inhibitor CLI-095 significantly reduced CD4+T cell death induced by GP. EBOV stimulation of primary CD4+T cells resulted in a significant increase in secreted TNFα; inhibition of TNFα-mediated signaling events significantly reduced T cell death while inhibitors of both necrosis and apoptosis similarly reduced EBOV-induced T cell death. Lastly, we show that stimulation with EBOV or GP augments monocyte maturation as determined by an overall increase in expression levels of markers of differentiation. Subsequently, the increased rates of cellular differentiation resulted in higher rates of infection further contributing to T cell death. These results demonstrate that GP directly subverts the host’s immune response by increasing the susceptibility of monocytes to EBOV infection and triggering lymphopenia through direct and indirect mechanisms.

Original languageEnglish (US)
Article numbere1006397
JournalPLoS Pathogens
Volume13
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Ebolavirus
Glycoproteins
T-Lymphocytes
Infection
Cell Death
Ebola Hemorrhagic Fever
Lymphopenia
Gene Expression Profiling
Monocytes
Necrosis
Apoptosis
Pattern Recognition Receptors
Systemic Inflammatory Response Syndrome
Fatal Outcome
Differentiation Antigens
Immunoprecipitation
Cell Communication
Interferons

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Molecular Biology
  • Genetics
  • Virology

Cite this

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. / Iampietro, Mathieu; Younan, Patrick; Nishida, Andrew; Dutta, Mukta; Lubaki, Ndongala Michel; Santos, Rodrigo I.; Koup, Richard A.; Katze, Michael G.; Bukreyev, Alexander.

In: PLoS Pathogens, Vol. 13, No. 5, e1006397, 01.05.2017.

Research output: Contribution to journalArticle

Iampietro, M, Younan, P, Nishida, A, Dutta, M, Lubaki, NM, Santos, RI, Koup, RA, Katze, MG & Bukreyev, A 2017, 'Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection', PLoS Pathogens, vol. 13, no. 5, e1006397. https://doi.org/10.1371/journal.ppat.1006397
Iampietro M, Younan P, Nishida A, Dutta M, Lubaki NM, Santos RI et al. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. PLoS Pathogens. 2017 May 1;13(5). e1006397. https://doi.org/10.1371/journal.ppat.1006397
Iampietro, Mathieu ; Younan, Patrick ; Nishida, Andrew ; Dutta, Mukta ; Lubaki, Ndongala Michel ; Santos, Rodrigo I. ; Koup, Richard A. ; Katze, Michael G. ; Bukreyev, Alexander. / Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. In: PLoS Pathogens. 2017 ; Vol. 13, No. 5.
@article{4852e644454a408dada4d0b59fbfc365,
title = "Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection",
abstract = "Fatal outcomes of Ebola virus (EBOV) infections are typically preceded by a ‘sepsis-like’ syndrome and lymphopenia despite T cells being resistant to Ebola infection. The mechanisms that lead to T lymphocytes death remain largely unknown; however, the degree of lymphopenia is highly correlative with fatalities. Here we investigated whether the addition of EBOV or its envelope glycoprotein (GP) to isolated primary human CD4+T cells induced cell death. We observed a significant decrease in cell viability in a GP-dependent manner, which is suggestive of a direct role of GP in T cell death. Using immunoprecipitation assays and flow cytometry, we demonstrate that EBOV directly binds to CD4+T cells through interaction of GP with TLR4. Transcriptome analysis revealed that the addition of EBOV to CD4+T cells results in the significant upregulation of pathways associated with interferon signaling, pattern recognition receptors and intracellular activation of NFκB signaling pathway. Both transcriptome analysis and specific inhibitors allowed identification of apoptosis and necrosis as mechanisms associated with the observed T cell death following exposure to EBOV. The addition of the TLR4 inhibitor CLI-095 significantly reduced CD4+T cell death induced by GP. EBOV stimulation of primary CD4+T cells resulted in a significant increase in secreted TNFα; inhibition of TNFα-mediated signaling events significantly reduced T cell death while inhibitors of both necrosis and apoptosis similarly reduced EBOV-induced T cell death. Lastly, we show that stimulation with EBOV or GP augments monocyte maturation as determined by an overall increase in expression levels of markers of differentiation. Subsequently, the increased rates of cellular differentiation resulted in higher rates of infection further contributing to T cell death. These results demonstrate that GP directly subverts the host’s immune response by increasing the susceptibility of monocytes to EBOV infection and triggering lymphopenia through direct and indirect mechanisms.",
author = "Mathieu Iampietro and Patrick Younan and Andrew Nishida and Mukta Dutta and Lubaki, {Ndongala Michel} and Santos, {Rodrigo I.} and Koup, {Richard A.} and Katze, {Michael G.} and Alexander Bukreyev",
year = "2017",
month = "5",
day = "1",
doi = "10.1371/journal.ppat.1006397",
language = "English (US)",
volume = "13",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection

AU - Iampietro, Mathieu

AU - Younan, Patrick

AU - Nishida, Andrew

AU - Dutta, Mukta

AU - Lubaki, Ndongala Michel

AU - Santos, Rodrigo I.

AU - Koup, Richard A.

AU - Katze, Michael G.

AU - Bukreyev, Alexander

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Fatal outcomes of Ebola virus (EBOV) infections are typically preceded by a ‘sepsis-like’ syndrome and lymphopenia despite T cells being resistant to Ebola infection. The mechanisms that lead to T lymphocytes death remain largely unknown; however, the degree of lymphopenia is highly correlative with fatalities. Here we investigated whether the addition of EBOV or its envelope glycoprotein (GP) to isolated primary human CD4+T cells induced cell death. We observed a significant decrease in cell viability in a GP-dependent manner, which is suggestive of a direct role of GP in T cell death. Using immunoprecipitation assays and flow cytometry, we demonstrate that EBOV directly binds to CD4+T cells through interaction of GP with TLR4. Transcriptome analysis revealed that the addition of EBOV to CD4+T cells results in the significant upregulation of pathways associated with interferon signaling, pattern recognition receptors and intracellular activation of NFκB signaling pathway. Both transcriptome analysis and specific inhibitors allowed identification of apoptosis and necrosis as mechanisms associated with the observed T cell death following exposure to EBOV. The addition of the TLR4 inhibitor CLI-095 significantly reduced CD4+T cell death induced by GP. EBOV stimulation of primary CD4+T cells resulted in a significant increase in secreted TNFα; inhibition of TNFα-mediated signaling events significantly reduced T cell death while inhibitors of both necrosis and apoptosis similarly reduced EBOV-induced T cell death. Lastly, we show that stimulation with EBOV or GP augments monocyte maturation as determined by an overall increase in expression levels of markers of differentiation. Subsequently, the increased rates of cellular differentiation resulted in higher rates of infection further contributing to T cell death. These results demonstrate that GP directly subverts the host’s immune response by increasing the susceptibility of monocytes to EBOV infection and triggering lymphopenia through direct and indirect mechanisms.

AB - Fatal outcomes of Ebola virus (EBOV) infections are typically preceded by a ‘sepsis-like’ syndrome and lymphopenia despite T cells being resistant to Ebola infection. The mechanisms that lead to T lymphocytes death remain largely unknown; however, the degree of lymphopenia is highly correlative with fatalities. Here we investigated whether the addition of EBOV or its envelope glycoprotein (GP) to isolated primary human CD4+T cells induced cell death. We observed a significant decrease in cell viability in a GP-dependent manner, which is suggestive of a direct role of GP in T cell death. Using immunoprecipitation assays and flow cytometry, we demonstrate that EBOV directly binds to CD4+T cells through interaction of GP with TLR4. Transcriptome analysis revealed that the addition of EBOV to CD4+T cells results in the significant upregulation of pathways associated with interferon signaling, pattern recognition receptors and intracellular activation of NFκB signaling pathway. Both transcriptome analysis and specific inhibitors allowed identification of apoptosis and necrosis as mechanisms associated with the observed T cell death following exposure to EBOV. The addition of the TLR4 inhibitor CLI-095 significantly reduced CD4+T cell death induced by GP. EBOV stimulation of primary CD4+T cells resulted in a significant increase in secreted TNFα; inhibition of TNFα-mediated signaling events significantly reduced T cell death while inhibitors of both necrosis and apoptosis similarly reduced EBOV-induced T cell death. Lastly, we show that stimulation with EBOV or GP augments monocyte maturation as determined by an overall increase in expression levels of markers of differentiation. Subsequently, the increased rates of cellular differentiation resulted in higher rates of infection further contributing to T cell death. These results demonstrate that GP directly subverts the host’s immune response by increasing the susceptibility of monocytes to EBOV infection and triggering lymphopenia through direct and indirect mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=85020202678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020202678&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1006397

DO - 10.1371/journal.ppat.1006397

M3 - Article

VL - 13

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 5

M1 - e1006397

ER -